Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit
Current Oncology · 06.08.2024 · 31 (8) · 4519-4530
DOI: 10.3390/curroncol31080337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 06.08.2024. Verfasst von Genevieve Dall und 8 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Comprehensive Cancer Centre Alliance (VCCC Alliance), Victorian Comprehensive Cancer Centre, Parkville, VIC 3052, Australia. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Genomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Government, Victorian Department of Health, Roche and AstraZenec.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The Victorian Precision Oncology Summit, convened in 2023, was a joint initiative between the Victorian Comprehensive Cancer Centre Alliance (VCCC Alliance) and the Monash Partners Comprehensive Cancer Consortium (MPCCC) and was proposed to guide a coordinated state-wide conversation about how the oncology sector can overcome some of the current obstacles in achieving equity of access to clinical cancer genomics for Victorian patients. Themes that emerged from discussion groups at the Summit include standardisation, centralisation, funding, education and communication and insights across those themes are outlined in this manuscript. The event served as a large consultation piece for the development of a broader precision oncology roadmap, which explores equitable access to molecular testing for Victorian patients, currently in development by the VCCC Alliance and MPCCC in collaboration with other key Victorian and national stakeholders. While this symposium was a Victorian initiative, it is felt that the insights garnered from this consultation piece will be of interest to consumer groups, clinicians, researchers, educators, policy makers and other key stakeholders in other states of Australia as well as in other countries implementing comprehensive genomic profiling within complex health systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Victorian Comprehensive Cancer Centre Alliance (VCCC Alliance), Victorian Comprehensive Cancer Centre, Parkville, VIC 3052, Australia.
- Monash Partners Comprehensive Cancer Consortium (MPCCC), Monash University, Clayton, VIC 3800, Australia.
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Parkville, VIC 3052, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3052, Australia.
- Department of Medical Oncology, Monash Health and Monash University, Clayton, VIC 3168, Australia.
ORCID-Profile: Daphne Day, Mark Buzza
Förderung
- Victorian Government
- Victorian Department of Health, Roche and AstraZenec
Zitieren
APA
Dall, G., Harris, K., Chan, N., Luen, S. J., Frentzas, S., Day, D., Barrett, M., Kilgour, A., & Buzza, M. (2024). Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit. Current Oncology, 31(8), 4519-4530. https://doi.org/10.3390/curroncol31080337
Vancouver
Dall G, Harris K, Chan N, Luen SJ, Frentzas S, Day D, et al. Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit. Current Oncology. 2024;31(8):4519-4530. doi:10.3390/curroncol31080337
BibTeX
@article{Dall2024,
author = {Dall, Genevieve and Harris, Karen and Chan, Nonie and Luen, Stephen J and Frentzas, Sophia and Day, Daphne and Barrett, Michelle and Kilgour, Anna and Buzza, Mark},
title = {Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {8},
pages = {4519--4530},
doi = {10.3390/curroncol31080337}
}
EUVIMED